# The Expression of Aquaporin 3, 8 and 9 in Placenta in Normal and Preeclamptic Pregnancies: Perinatal and Neonatal Outcomes.

> **NCT02045316** · — · UNKNOWN · sponsor: **Rakhshanda Aslanova** · enrollment: 210 (estimated)

## Conditions studied

- Preeclampsia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02045316
- **Lead sponsor:** Rakhshanda Aslanova
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2014-06
- **Final completion:** 2014-07
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2014-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02045316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02045316, "The Expression of Aquaporin 3, 8 and 9 in Placenta in Normal and Preeclamptic Pregnancies: Perinatal and Neonatal Outcomes.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02045316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*